MLH1 and colorectal carcinoma: In particular, BRAF mutations and CpG island methylator phenotype (CIMP), together with loss of MLH1 in dysplastic SSLs, have been described in IBD cohorts [27,31], suggesting that a serrated route to CRC may operate alongside the conventional adenoma–carcinoma sequence, especially in long-standing colitis [59].